Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing
PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection
Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415